Mindfulness, Burnout, Anxiety, SleepMiMTNCT05605041
Mindfulness in Medical Training
A study testing Headspace in people with Mindfulness, Burnout, Anxiety, Sleep, run by University of Arizona.
Trial summary
Headspace, a smartphone application that provides guided meditation, mindfulness and sleep exercises, will be used as the intervention in improving sleep, anxiety, depression and burnout in all participating individuals selected from the University of Arizona College of Medicine-Tucson residents and fellows. Read more about this study
- Who is it for?
- Any ageHealthy volunteers can take part
- Conditions the study is for
- Mindfulness, Burnout, Anxiety, Sleep
- What is being tested?
- Headspace
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 0 participants
- Where
- No sites listed yet
- Study dates
- Dec 2022to Feb 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Who may be able to join
- University of Arizona resident or fellow
Who cannot join
- none
About this study
Official title: Mindfulness in Medical Training: Using Headspace to Improve Sleep, Anxiety, and Burnout Among Resident Physicians
Headspace, a smartphone application that provides guided meditation, mindfulness and sleep exercises, will be used as the intervention in improving sleep, anxiety, depression and burnout in all participating individuals selected from the University of Arizona College of Medicine-Tucson residents and fellows.
Read the detailed description
The intervention of of daily meditation with the Headspace application will be used to determine if this is a possible effective intervention for decreasing the feeling of burnout. It is being proposed that it could improve the subjects' well-being both in the short-term and long term. The primary outcomes will be burnout, anxiety, depression and sleep. This study will use the Maslach Burnout Inventory to assess baseline burnout, as well as at 30 and 90 days post-intervention period. Sleep and anxiety and depression will be assessed using the Epworth Sleepiness Scale and Hospital Anxiety and Depression Scale (HADS) scores at the same intervals.
- Conditions
- Mindfulness, Burnout, Anxiety, Sleep
- Being tested
- Headspace
- Medical subject headings
- Burnout, Psychological, Anxiety Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
HeadspaceDevice
Headspace is an app that allows users to practice mindfulness through guided meditation
| Study group | Role | What they receive |
|---|---|---|
| Did Not Use Headspace | No intervention | Those that did not use headspace during the time the study is conducted |
| Did Use Headspace | Experimental | Those that were randomized into the group and used Headspace at least once during the study period Receives: Device: Headspace |
What is being measured
The primary outcome is the main question the study is designed to answer.
The Effects on Burnout
The intervention group will be asked to fill out the Maslachs Burnout Inventory (MBI) survey prior to intervention starting, 30 days after start of intervention and then again at 90 days after start of intervention). the MBI is a measure of three independent constructs - emotional exhaustion, depersonalization, and personal accomplishment. Lower scores will indicate less of an impact on those constructs. Higher scores indicate a stronger impact on those constructs. A score for emotional exhaustion includes anything <27, a low score is 0-18. For Depersonalisation a high score is anything >10 and a low score is 0-5. For Personal accomplishment a high score is 0-33 and low score is anything >40
Measured: 30-90 days
The Effects on Sleep
The intervention group will be asked to fill out the Epworth Sleepiness Scale survey prior to intervention starting, 30 days after start of intervention and then again at 90 days after start of intervention). The scores will be analyzed to determine impact on sleep. Lower scores indicate a normal range of sleepiness, higher scores (18-24) will be indicative of severe sleepiness. Lower scores of 0-10 will be indicative of a normal range of sleepiness in healthy adults.
Measured: 30-90 days
The effects on Anxiety and Depression
The intervention group will be asked to fill out the GAD-7 (Generalized Anxiety Disorder) questionnaire prior to intervention starting, 30 days after start of intervention and then again at 90 days after start of intervention. The scores will be analyzed to determine impact on anxiety and depression. Lower versus higher scores will be proportional to how much anxiety and depression that person is facing. A score of 0-4 is indicative of minimal anxiety and a score of > 15 is indicative of severe anxiety.
Measured: 30-90 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted4 Nov 2022
- Study startDec 2022 (estimated)
- Primary completionDec 2022 (estimated)
- Study completionFeb 2023 (estimated)
Why it stopped: Not enough resources to proceed with the study
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Mindfulness, Burnout, Anxiety, SleepStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 0 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Arizona
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05605041
- Sponsor's protocol ID
- STUDY00000063
- Acronym
- MiMT
- Status last verified
- Jul 2022
- First submitted
- 1 Jun 2022
- Last updated
- 3 Aug 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 3 Aug 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Mindfulness in Medical Training: Using Headspace to Improve Sleep, Anxiety, and Burnout Among Resident Physicians
- ClinicalTrials.gov ID
- NCT05605041
- Acronym / sponsor ID
- MiMT / STUDY00000063
- Conditions
- Mindfulness, Burnout, Anxiety, Sleep
- Study type
- Interventional
- Recruitment status
- WithdrawnReason stopped: Not enough resources to proceed with the study
- Enrolment
- 0 participants (actual)
- Lead sponsor
- University of ArizonaUniversity, hospital or other
- Study start
- Dec 2022 (estimated)
- Primary completion
- Dec 2022 (estimated)
- Study completion
- Feb 2023 (estimated)
- First posted
- 4 Nov 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Headspace, a smartphone application that provides guided meditation, mindfulness and sleep exercises, will be used as the intervention in improving sleep, anxiety, depression and burnout in all participating individuals selected from the University of Arizona College of Medicine-Tucson residents and fellows.
Detailed description
The intervention of of daily meditation with the Headspace application will be used to determine if this is a possible effective intervention for decreasing the feeling of burnout. It is being proposed that it could improve the subjects' well-being both in the short-term and long term. The primary outcomes will be burnout, anxiety, depression and sleep. This study will use the Maslach Burnout Inventory to assess baseline burnout, as well as at 30 and 90 days post-intervention period. Sleep and anxiety and depression will be assessed using the Epworth Sleepiness Scale and Hospital Anxiety and Depression Scale (HADS) scores at the same intervals.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Did Not Use Headspace | No intervention | –Those that did not use headspace during the time the study is conducted |
| Did Use Headspace | Experimental | Device: HeadspaceThose that were randomized into the group and used Headspace at least once during the study period |
Who may qualify
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (1 listed)
- University of Arizona resident or fellow
Key exclusion criteria (1 listed)
- none
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| HeadspaceHeadspace is an app that allows users to practice mindfulness through guided meditation | Device | Did Use Headspace |
Primary outcome
The Effects on Burnout
Time frame: 30-90 days
The intervention group will be asked to fill out the Maslachs Burnout Inventory (MBI) survey prior to intervention starting, 30 days after start of intervention and then again at 90 days after start of intervention). the MBI is a measure of three independent constructs - emotional exhaustion, depersonalization, and personal accomplishment. Lower scores will indicate less of an impact on those constructs. Higher scores indicate a stronger impact on those constructs. A score for emotional exhaustion includes anything <27, a low score is 0-18. For Depersonalisation a high score is anything >10 and a low score is 0-5. For Personal accomplishment a high score is 0-33 and low score is anything >40
The Effects on Sleep
Time frame: 30-90 days
The intervention group will be asked to fill out the Epworth Sleepiness Scale survey prior to intervention starting, 30 days after start of intervention and then again at 90 days after start of intervention). The scores will be analyzed to determine impact on sleep. Lower scores indicate a normal range of sleepiness, higher scores (18-24) will be indicative of severe sleepiness. Lower scores of 0-10 will be indicative of a normal range of sleepiness in healthy adults.
The effects on Anxiety and Depression
Time frame: 30-90 days
The intervention group will be asked to fill out the GAD-7 (Generalized Anxiety Disorder) questionnaire prior to intervention starting, 30 days after start of intervention and then again at 90 days after start of intervention. The scores will be analyzed to determine impact on anxiety and depression. Lower versus higher scores will be proportional to how much anxiety and depression that person is facing. A score of 0-4 is indicative of minimal anxiety and a score of > 15 is indicative of severe anxiety.
Results and safety
The study was withdrawn before enrolling participants, so there are no results.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Aug 2025.
- Individual participant dataSharing planned: Yes
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
A study testing Headspace in people with Mindfulness, Burnout, Anxiety, Sleep, run by University of Arizona.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: withdrawn, as of the sponsor's last update on 3 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was withdrawn before enrolling participants, so there are no results.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
The Effects on Burnout (time frame: 30-90 days). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Aug 2025.